Product Safety Recalls

Product Recall Tracker

FLUTICASONE PROPIONATE Recall D-0202-2024

Description: Inhub Wixela (fluticasone propionate and salmeterol inhalation powder, USP) 500/50MCG, 60 Doses of Inhalation Powder, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505. NDC: 0378-9320-32

FLUTICASONE PROPIONATE Recall D-0202-2024 Information

StatusCompleted
Mandated?Voluntary: Firm initiated
Recall NumberD-0202-2024
Event ID89450
BrandWIXELA INHUB
Generic NameFLUTICASONE PROPIONATE AND SALMETEROL
ManufacturerFLUTICASONE PROPIONATE AND SALMETEROL
Original Package?1
Active SubstanceFLUTICASONE PROPIONATE SALMETEROL XINAFOATE
Drug RouteRESPIRATORY (INHALATION)
DistributionNationwide USA
Quantity1 unit
Recall ReasonCGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Drug ClassificationClass II
Drug Code Info20240103
Product NDC0378-9320 0378-9321 0378-9322
Recall Initiation Date20220126
Report Date20240103
Classification Date20231226
Address7200 Cardinal Pl W
Dublin, OH 43017-1094
United States
Recalling FirmCARDINAL HEALTHCARE
Initial Notification Letter
Unique Ingredient IdentifierO2GMZ0LF5W 6EW8Q962A5
Drug Application NumberANDA208891
Structured Product Labeling (SPL ID)03d33612-03b4-4a2c-ba86-47816db363ce
Structured Product Labeling (SPL Set ID)3beef422-8a07-4a45-9ba6-414511e4b7e2
Similar To

© 2022 Recall.Report / Contact / Privacy Policy

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied.
Recall.report is not affiliated with the Consumer Product Safety Commision, FDA, or US government in any way.